Clostridioides difficile infections, recurrences, and clinical outcomes in real-world settings from 2015 to 2019: The RECUR England study

被引:3
|
作者
Ghosh, Subrata [1 ,2 ]
Antunes, Ana [3 ,9 ]
Rinta-Kokko, Hanna [4 ]
Chaparova, Elena [5 ]
Lay-Flurrie, Sarah [6 ]
Tricotel, Aurore [7 ]
Andersson, Fredrik L. [8 ]
机构
[1] Univ Coll Cork, Coll Med & Hlth, Cork, Ireland
[2] Univ Birmingham, Birmingham, England
[3] IQVIA, Real World Solut, Global Database Studies, Lisbon, Portugal
[4] IQVIA, Real World Solut, Global Database Studies, Espoo, Finland
[5] IQVIA, Real World Solut, Sofia, Bulgaria
[6] IQVIA, Real World Solut, London, England
[7] IQVIA, Real World Solut, Paris, France
[8] Ferring Pharmaceut, Copenhagen, Denmark
[9] IQVIA, Lagoas Pk,Edificio 3, P-2740266 Lisbon, Portugal
关键词
Clostridioides difficile infection; Recurrent clostridioides difficile infection; Epidemiological; Real-world study; England; RECUR; RISK; DISEASE;
D O I
10.1016/j.ijid.2024.01.002
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objective: To estimate the epidemiological and clinical burden of Clostridioides difficile infections (CDIs) and recurrences (rCDIs) in England. Methods: This retrospective study included adult patients diagnosed with CDI (community or hospital settings) over 2015-2019 from Clinical Practice Research Datalink and Hospital Episode Statistics databases. Incidences of CDI and rCDI were determined annually. Time to subsequent rCDI was estimated by Kaplan-Meier method. Rates of complications were assessed within 12 months from index episode. Association of risk factors with complications was evaluated using a Cox regression model. Results: A total of 52,443 CDI episodes were recorded among 36,913 patients. Of these, 75% were aged >= 65 years, 59% were women; 73% were treated in community settings. CDI incidence remained stable (111 episodes per 10 0,0 0 0 patients in 2019). Around 21% of patients had >= 1 rCDI. Sepsis (12%) was the most common complication, followed by colectomy and ulcerative colitis. Age, gender, comorbidities, rCDI, preindex medical procedures, hospitalizations and consultations, and CDI treatment in hospital, were found to increase the risk of complication. Conclusions: CDI remains a concern in England. The study highlights the importance of managing primary and rCDI episodes via effective and improved therapies to prevent fatal complications. (c) 2024 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )
引用
收藏
页码:31 / 38
页数:8
相关论文
共 50 条
  • [31] Differences in Clinical Outcomes between Patients with and without Hypoglycemia during Hospitalization: A Retrospective Study Using Real-World Evidence
    Lee, Jeongmin
    Kim, Tong Min
    Kim, Hyunah
    Lee, Seung-Hwan
    Cho, Jae Hyoung
    Lee, Hyunyong
    Yim, Hyeon Woo
    Yoon, Kun-Ho
    Kim, Hun-Sung
    DIABETES & METABOLISM JOURNAL, 2020, 44 (04) : 555 - +
  • [32] Effects of Pregnancy and Breastfeeding on Clinical Outcomes and MRI Measurements of Women with Multiple Sclerosis: An Exploratory Real-World Cohort Study
    Lorefice, Lorena
    Fronza, Marzia
    Fenu, Giuseppe
    Frau, Jessica
    Coghe, Giancarlo
    D'Alterio, Maurizio Nicola
    Barracciu, Maria Antonietta
    Murgia, Federica
    Angioni, Stefano
    Cocco, Eleonora
    NEUROLOGY AND THERAPY, 2022, 11 (01) : 39 - 49
  • [33] Long-Term clinical efficacy of liraglutide for type 2 diabetes: real-world evidence and outcomes from Pakistan
    Butt, Muhammad Daoud
    Ong, Siew Chin
    Rafiq, Azra
    Batool, Nighat
    Saifi, Rumana
    Yaseen, Samina
    Kaukab, Irum
    Ramzan, Basit
    JOURNAL OF PHARMACEUTICAL POLICY AND PRACTICE, 2024, 17 (01)
  • [34] Treatment Settings and Outcomes with Regorafenib and Trifluridine/Tipiracil at Third-Line Treatment and beyond in Metastatic Colorectal Cancer: A Real-World Multicenter Retrospective Study
    Signorelli, Carlo
    Calegari, Maria Alessandra
    Basso, Michele
    Anghelone, Annunziato
    Lucchetti, Jessica
    Minelli, Alessandro
    Angotti, Lorenzo
    Zurlo, Ina Valeria
    Schirripa, Marta
    Chilelli, Mario Giovanni
    Morelli, Cristina
    Dell'Aquila, Emanuela
    Cosimati, Antonella
    Gemma, Donatello
    Ribelli, Marta
    Emiliani, Alessandra
    Corsi, Domenico Cristiano
    Arrivi, Giulia
    Mazzuca, Federica
    Zoratto, Federica
    Morandi, Maria Grazia
    Santamaria, Fiorenza
    Saltarelli, Rosa
    Ruggeri, Enzo Maria
    CURRENT ONCOLOGY, 2023, 30 (06) : 5456 - 5469
  • [35] Clinical characteristics and outcomes of gastrointestinal stromal tumor patients receiving surgery with or without TKI therapy: a retrospective real-world study
    Wang, Lingquan
    Ni, Zhentian
    Xu, Wei
    Mei, Yu
    Li, Chen
    Zhu, Zhenggang
    Liu, Wentao
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [36] Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China
    Xiao, Xiang
    Ji, Shuming
    Zheng, Tao
    Wang, Tianzhu
    Jiang, Dapeng
    Liu, Fang
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [37] Clinical management of children with tic disorder: insights from therapeutic visits in China-a real-world study
    Wang, Jing
    Luo, Changyong
    Wang, Zhendong
    Liu, Tiegang
    Bai, Chen
    Wang, Yang
    Tian, Yuanshuo
    Li, Qianqian
    Wang, Zhaoxin
    Wu, Liqun
    Wang, Sumei
    Gu, Xiaohong
    FRONTIERS IN PEDIATRICS, 2024, 12
  • [38] Real-world clinical and economic outcomes from rapid start antiretroviral therapy in HIV: systematic review and meta-analysis
    Duong, Khanh N. C.
    Schmutz, Howard Weston
    Ben-Umeh, Kenechukwu C.
    Duru, Emeka E.
    Rose, Natalie
    Trom, Cassidy
    Chaiyakunapruk, Nathorn
    Willis, Connor
    AIDS, 2025, 39 (03) : 241 - 252
  • [39] Disparities in economic burden for children with leukemia insured by resident basic medical insurance: evidence from real-world data 2015-2019 in Guangdong, China
    Zhan, Chunwang
    Wu, Zhiming
    Yang, Lihua
    Yu, Lihua
    Deng, Jie
    Luk, Kiuco
    Duan, Chongyang
    Zhang, Luwen
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [40] Four-factor prothrombin complex concentrates for warfarin reversal: do real-world outcomes differ from controlled clinical trials?
    Pruthi, R. K.
    TRANSFUSION, 2016, 56 (04) : 784 - 786